Haemorheological effects of fructose-1,6-diphosphate in patients with lower extremity ischaemia
Authors:
- 1 January 1988
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 10 (10) , 668-674
Abstract
A prospective, single-blind study was carried out in 30 patients with obstructive peripheral artery disease to investigate the haemorheological properties of fructose-1,6-diphosphate (FDP). Patients were allocated at random to receive 7 to 10-days' treatment with either 10 g of 10% FDP twice daily or saline. Measurements were made on entry and at the end of treatment of whole blood and plasma viscosity, erythrocyte deformability and aggregation, and lower limb blood flow was evaluated by Doppler technique. FDP treatment was associated with a reduction in whole blood viscosity (24%) and red blood cell aggregation index (27%), and an improvement in red blood cell deformability (42%) (p<0.01). No significant changes were observed in the control group. Plasma viscosity did not change in either treatment group. Limb blood flow increased (p<0.05) only in patients treated with FDP; the improvement was more pronounced in the most severely affected side (30%). No untoward events were observed or reported in any of the patients studied.Keywords
This publication has 4 references indexed in Scilit:
- Increase of intraerythrocytic fructose-1,6-diphosphate after incubation of whole human blood with fructose-1,6-diphosphateClinical Biochemistry, 1984
- A simple method for measuring erythrocyte deformability.Journal of Clinical Pathology, 1976
- The action of phosphocreatine and fructose 1,6-diphosphate on blood in vitroResuscitation, 1976
- Intracellular Organic Phosphates as Regulators of Oxygen Release by HaemoglobinNature, 1969